XML 34 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2020
Reconciliation of Numerators and Denominators used in Computing Basic and Diluted Net Income Per Share
The following is a reconciliation of the numerators and denominators used in computing basic and diluted net income per share:
 
   
Three Months Ended
   
Six Months Ended
 
   
June 30,
2020
   
June 30,
2019
   
June 30,
2020
   
June 30,
2019
 
Net income (loss)
  $(4,098,623  $(2,774,282  $(6,996,598  $(3,942,168
  
 
 
   
 
 
   
 
 
   
 
 
 
Numerator, basic and diluted net income (loss) available to stockholders
  $(4,098,623  $(2,774,282  $(6,996,598  $(3,942,168
  
 
 
   
 
 
   
 
 
   
 
 
 
Denominator:
        
Shares used in computation – basic:
        
Weighted average common shares outstanding
   9,542,449    9,224,318    9,530,056    9,223,264 
  
 
 
   
 
 
   
 
 
   
 
 
 
Common shares outstanding for basic
   9,542,449    9,224,318    9,530,056    9,223,264 
  
 
 
   
 
 
   
 
 
   
 
 
 
 
   
Three Months Ended
   
Six Months Ended
 
   
June 30,
2020
   
June 30,
2019
   
June 30,
2020
   
June 30,
2019
 
Shares used in computation – diluted:
        
Common shares outstanding for basic
   9,542,449    9,224,318    9,530,056    9,223,264 
  
 
 
   
 
 
   
 
 
   
 
 
 
Shares used in computing diluted net income per share
   9,542,449    9,224,318    9,530,056    9,223,264 
  
 
 
   
 
 
   
 
 
   
 
 
 
Net (loss) per share – basic
  $(0.43  $(0.30  $(0.73  $(0.43
Net (loss) per share – diluted
  $(0.43  $(0.30  $(0.73  $(0.43
Schedule of Financial Instruments at Fair Value on a Recurring Basis
We measure certain financial instruments at fair value on a recurring basis. The Company had liabilities that are required to be measured at fair value on a recurring basis as follows at June 30, 2020:
 
   
Total
   
Level 1
   
Level 2
   
Level 3
 
Assets:
  $—     $—     $—     $—   
  
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities:
        
Hybrid debt instrument at fair value
  $1,776,700   $—     $—     $1,776,700 
  
 
 
   
 
 
   
 
 
   
 
 
 
Reconciliation of the Beginning and Ending Balances for the Liability Measured at Fair Value on a Recurring Basis
The following is a reconciliation of the beginning and ending balances for the liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year December 31, 2019: See NOTE I: Note 10 – 37North for further detail.
 
Balance at December 31, 2019
  $861,485 
Additional debt issuances
   490,000 
Loss in hybrid-instrument fair value
   425,215 
  
 
 
 
Balance at June 30, 2020
  $1,776,700 
  
 
 
 
In the Money Potential Common Shares [Member]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The potential common shares in the following tables represent potential common shares calculated using the treasury stock method from outstanding options, stock awards and warrants that were excluded from the calculation of diluted EPS:
 
   
Three Months Ended
   
Six Months Ended
 
   
June 30,

2020
   
June 30,

2019
   
June 30,

2020
   
June 30,

2019
 
Average market price during the period
  $4.27   $5.24   $4.04   $5.68 
In the money potential common shares from options excluded
   22,493    10,743    22,493    11,652 
In the money potential common shares from warrants excluded
   633,784    39,390    633,784    45,633 
Out of Money Potential Common Shares [Member]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Potential common shares from out of the money options and warrants were also excluded from the computation of diluted EPS because calculation of the associated potential common shares has an anti-dilutive effect on EPS. The following table lists options and warrants that were excluded from diluted EPS:
 
   
Three Months Ended
   
Six-Months
Ended
 
Per share
exercise price
  
June 30,
2020
   
June 30,
2019
   
June 30,
2020
   
June 30,
2019
 
Out of the money options excluded:
 
    
$12.48   136,833   136,833   136,833   136,833
$12.84   4,167    4,167    4,167    4,167 
$26.40   75,158    75,158    75,158    75,158 
Out-of-the-money
warrants excluded:
 
    
$5.76   196,135   —      196,135   —   
$7.16   700,000   700,000   700,000   700,000
$12.00   —      65,625   —      65,625
  
 
 
   
 
 
   
 
 
   
 
 
 
Total excluded
   1,112,293    981,783    1,112,293    981,783 
  
 
 
   
 
 
   
 
 
   
 
 
 
Unvested Restricted Stock Awards Excluded from EPS [Member]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The common shares relating to our unvested restricted stock awards that were excluded from potential common shares in the earning per share calculation due to having an anti-dilutive effect are:
 
   
Three Months Ended
   
Six Months Ended
 
   
June 30,
2020
   
June 30,
2019
   
June 30,
2020
   
June 30,
2019
 
Potential common shares from unvested restricted stock awards excluded from EPS
   343,353    41,667    343,353    41,667